Free Trial

Compugen (CGEN) Stock Price, News & Analysis

Compugen logo
$1.54 -0.05 (-3.14%)
Closing price 04:00 PM Eastern
Extended Trading
$1.54 -0.01 (-0.32%)
As of 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Compugen Stock (NASDAQ:CGEN)

Key Stats

Today's Range
$1.53
$1.64
50-Day Range
$1.26
$1.83
52-Week Range
$1.13
$2.66
Volume
255,857 shs
Average Volume
364,846 shs
Market Capitalization
$137.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
Consensus Rating
Buy

Company Overview

Compugen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

CGEN MarketRank™: 

Compugen scored higher than 33% of companies evaluated by MarketBeat, and ranked 771st out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Compugen has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Compugen has received no research coverage in the past 90 days.

  • Read more about Compugen's stock forecast and price target.
  • Earnings Growth

    Earnings for Compugen are expected to decrease in the coming year, from ($0.03) to ($0.12) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Compugen is -9.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Compugen is -9.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Compugen has a P/B Ratio of 2.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Compugen's valuation and earnings.
  • Percentage of Shares Shorted

    1.83% of the float of Compugen has been sold short.
  • Short Interest Ratio / Days to Cover

    Compugen has a short interest ratio ("days to cover") of 6.4.
  • Change versus previous month

    Short interest in Compugen has recently increased by 1.37%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Compugen does not currently pay a dividend.

  • Dividend Growth

    Compugen does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.83% of the float of Compugen has been sold short.
  • Short Interest Ratio / Days to Cover

    Compugen has a short interest ratio ("days to cover") of 6.4.
  • Change versus previous month

    Short interest in Compugen has recently increased by 1.37%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Compugen has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.96 average news sentiment score of Medical companies.
  • Search Interest

    Only 3 people have searched for CGEN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Compugen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.50% of the stock of Compugen is held by insiders.

  • Percentage Held by Institutions

    Only 12.22% of the stock of Compugen is held by institutions.

  • Read more about Compugen's insider trading history.
Receive CGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Compugen and its competitors with MarketBeat's FREE daily newsletter.

CGEN Stock News Headlines

This Could Be the Most Profitable Season of Your Life
Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending.
Compugen First Quarter 2025 Earnings: Misses Expectations
See More Headlines

CGEN Stock Analysis - Frequently Asked Questions

Compugen's stock was trading at $1.53 at the beginning of 2025. Since then, CGEN shares have increased by 0.7% and is now trading at $1.54.

Compugen Ltd. (NASDAQ:CGEN) posted its earnings results on Monday, May, 19th. The biotechnology company reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.02. The biotechnology company earned $2.28 million during the quarter, compared to analysts' expectations of $3.70 million. Compugen had a negative net margin of 51.27% and a negative trailing twelve-month return on equity of 24.51%.
Read the conference call transcript
.

Compugen's top institutional shareholders include Taylor Frigon Capital Management LLC (1.11%).

Shares of CGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Compugen investors own include Oramed Pharmaceuticals (ORMP), TransEnterix (TRXDW), NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), PayPal (PYPL) and

Company Calendar

Last Earnings
5/19/2025
Today
7/18/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CGEN
CIK
1119774
Employees
70
Year Founded
1993

Price Target and Rating

High Price Target
$4.00
Low Price Target
$4.00
Potential Upside/Downside
+159.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.23 million
Net Margins
-51.27%
Pretax Margin
-34.78%
Return on Equity
-24.51%
Return on Assets
-12.19%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.09
Quick Ratio
5.09

Sales & Book Value

Annual Sales
$27.86 million
Price / Sales
4.93
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.62 per share
Price / Book
2.48

Miscellaneous

Outstanding Shares
89,240,000
Free Float
80,759,000
Market Cap
$137.43 million
Optionable
Optionable
Beta
2.57

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:CGEN) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners